JR

Jason Rhodes

Chairman (and founding CEO) at Generation Bio

Cambridge, Massachusetts

Overview

Work Experience

  • Partner

    2014 - Current

  • Executive Chair (and founding CEO)

    2020

  • Chairman (and founding CEO)

    2016

    www.generationbio.com

  • Chairman (and founding CEO)

    2017

  • Presidential Advisory Council, Member

    2009 - 2022

  • Chairman (and founding CEO)

    2016 - 2020

  • President and CFO

    2010 - 2014

  • Vice President, Business Development

    2007 - 2010

    Alnylam is a biopharmaceutical company developing novel therapeutics based on RNAi. Led strategic collaborations with Takeda, GSK, Kyowa Hakko Kirin, Medtronic, Cubist and Roche, and spin out of Regulus (RGLS).

  • Partner

    2001 - 2007

    Biotech venture capital arm of Fidelity Investments. Led investments in therapeutics companies including FoldRx, acquired by Pfizer.

Education

Latest Articles

MediumDec. 2016

git+ is a lifestyle

Talks about Git, Github and git workflow

Relevant Websites